Skip to main content
Uma Borate, MD, Oncology, Columbus, OH, Ohio State University Wexner Medical Center

UmaMadhavBorateMD

Oncology • Columbus, OH

Hematologic Oncology

Assistant Professor, Medicine, University of Alabama School of Medicine

Join to view full profile

Dr. Borate is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Borate's full profile

Already have an account?

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2004 - 2008
  • B.J. Medical College - University of Pune
    B.J. Medical College - University of PuneClass of 2003

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2020 - 2024
  • OR State Medical License
    OR State Medical License 2016 - 2023
  • AL State Medical License
    AL State Medical License Active through 2016
  • PA State Medical License
    PA State Medical License 2004 - 2008
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Functional Genomic Landscape of Acute Myeloid Leukaemia  
    Marc M Loriaux, Christopher R Cogle, Patricia Kropf, Daniel A Pollyea, Uma Borate, Michael W Deininger, Nature

Abstracts/Posters

  • Dose Escalation Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
    Uma Borate, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodyspl...
    Uma Borate, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant Abstract
    Uma Borate, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Newly Diagnosed AML Patient Samples Demonstrate High Degree of Concordance in Identification of Pathogenic Mutations By Next Generation Sequencing (NGS) Performed at E... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • RGL4 over Expression Correlates with Variation in Midostaurin Response in FLT3-ITD Mutant AML Samples 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A Precision Medicine Heirarchical Classification Developed Using Variant Allele Frequency (VAF) for Treatment of Older Patients (Pts) with Acute Myeloid Leukemia (AML)... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Identification of Targeted Therapies for Rare Adult Mature T-cell Leukemia Using Functional Ex Vivo Screening of Primary Patient Samples
    Identification of Targeted Therapies for Rare Adult Mature T-cell Leukemia Using Functional Ex Vivo Screening of Primary Patient SamplesFebruary 9th, 2017
  • Social Factors Affect Leukemia Survival
    Social Factors Affect Leukemia SurvivalSeptember 14th, 2015

Hospital Affiliations

Dr. Uma Borate, Dr. Uma Borate, MD, Dr. U Borate, Dr. Uma Madhav Borate